Author: Dr. Shaun Larsen
Macular Degeneration Treatment Shots
Aflibercept, Lucentis and Eylea are three commonly prescribed injectable medications used to treat wet age-related macular degeneration (wet AMD). You will require injections every four weeks; at each visit your pupil will be dilated and an eye scan completed. Studies suggest that eating foods rich in lutein and zeaxanthin may help slow macular degeneration progression.…
Does Macular Degeneration Cause Blindness?
Age-related macular degeneration is a condition in which deterioration of the central portion of your retina at the back of the eye (macula) causes central vision to become blurry or hazy, leading to blurred or dimmed vision in people aged over 50 and is the leading cause of blindness among them. Macular degeneration often reduces…
New Treatment Options for Age-Related Macular Degeneration
Faricimab-svoa is an innovative treatment option to ease the treatment burden for wet AMD and retinal vascular disease, according to Pharmacy Times. It reportedly targets two disease pathways and may provide better vision outcomes with fewer injections compared with traditional therapies. Avacincaptad pegol is a complement C5 inhibitor which may slow progression of geographic atrophy…
Treatment For AMD Eye Disease
Age-related macular degeneration (AMD) is an eye condition that gradually destroys central vision. It occurs when light-sensing cells in the retina start to break down; initially this results in blurry vision before deposits known as drusen begin appearing beneath it. Wet AMD can be treated using injectable medications that block growth factors that encourage new…
New Treatment For Macular Degeneration 2023
The Food and Drug Administration has granted approval for two drugs to treat geographic atrophy (GA), an age-related macular degeneration complication. These two treatments include Avacincaptad Pegol and Faricimab-svoa. Genentech’s Vabysmo (faricimab-svoa) inhibits two disease pathways that contribute to retinal conditions that threaten vision. By inhibiting these two disease pathways, Vabysmo can help reduce retinal…
Injectable Medication Treatments For Macular Degeneration
Most people with macular degeneration suffer from dry forms; however, some also develop abnormal blood vessels underneath the macula that leak fluid and cause further vision loss (wet ARMD). There are injectable medications available that may prevent new blood vessels from growing under your macula and threaten vision further. Your ophthalmologist will perform an Amsler…
Stargardt Eye Disease Treatment
Stargardt disease is an inherited form of severe dry age-related macular degeneration characterized by lipofuscin deposits accumulating within the retinal pigment epithelium (RPE). Your ophthalmologist can diagnose Stargardt eye disease through an eye exam and genetic testing, as well as by performing fluorescein angiography to confirm and monitor its progress. 1. Steroid Eye Drops Stargardt…
What Are Eye Injections For Macular Degeneration?
Macular degeneration is a progressive loss of central vision that affects 8 million Americans over 50. It occurs when new blood vessels form (neovascularization) under the retina and leak blood or fluid into its surroundings. AMD may not have a cure, but medicines which suppress VEGF may slow its progress and even improve vision in…
What is the New Treatment for Macular Degeneration 2023?
Faricimab-svoa (Vabysmo) offers hope to those suffering from degenerative retinal conditions. By targeting and inhibiting two disease pathways associated with wet macular degeneration and diabetic macular edema, this new therapy may offer hope to patients in need of relief. Avacincaptad pegol targets complement C5, believed to play a part in geographic atrophy progression. This drug…
Anti-VEGF Treatment for Macular Degeneration
Anti-vascular endothelial growth factor (anti-VEGF) treatments have been demonstrated to successfully prevent vision loss in those suffering from wet age-related macular degeneration; however, they can increase intraocular pressure – something optometrists managing these patients with glaucoma should keep in mind. Sodhi’s team found that those able to enter a treatment pause enjoyed greater improvement and…
Does Medicare Cover Treatment For Macular Degeneration?
Medicare should play an instrumental role in preventing eye diseases from leading to vision loss or blindness and in mitigating costs associated with treating such conditions once they appear. Age-related macular degeneration (AMD), one of the most widespread retinal conditions, comes in two varieties – dry and wet forms. Diabetic Retinopathy Diabetes can damage small…
Treatment of AMD Eye Disease
At present, there is no cure for dry AMD; however, there may be ways to slow its progress. According to research by the National Eye Institute’s AREDS study, taking a high-dose formulation of antioxidants and zinc could prevent loss of vision caused by AMD. People living with dry AMD should seek regular dilated eye exams…
